Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Caused by AmpC β-Lactamase-Producing Enterobacter spp, Citrobacter freundii, Morganella morganii, Providencia spp, or Serratia marcescens: A Pilot Multicenter Randomized Controlled Trial (MERINO-2)

10.1093/ofid/ofab387

Saved in:
Bibliographic Details
Main Authors: Stewart, AG, Paterson, DL, Young, B, Lye, DC, Davis, JS, Schneider, K, Yilmaz, M, Dinleyici, R, Runnegar, N, Henderson, A, Archuleta, S, Kalimuddin, S, Forde, BM, Chatfield, MD, Bauer, MJ, Lipman, J, Harris-Brown, T, Harris, PNA
Other Authors: MEDICINE
Format: Article
Published: Oxford University Press (OUP) 2021
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/206194
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-206194
record_format dspace
spelling sg-nus-scholar.10635-2061942024-11-09T13:41:22Z Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Caused by AmpC β-Lactamase-Producing Enterobacter spp, Citrobacter freundii, Morganella morganii, Providencia spp, or Serratia marcescens: A Pilot Multicenter Randomized Controlled Trial (MERINO-2) Stewart, AG Paterson, DL Young, B Lye, DC Davis, JS Schneider, K Yilmaz, M Dinleyici, R Runnegar, N Henderson, A Archuleta, S Kalimuddin, S Forde, BM Chatfield, MD Bauer, MJ Lipman, J Harris-Brown, T Harris, PNA MEDICINE DUKE-NUS MEDICAL SCHOOL Assoc Prof Sophia Archuleta Enterobacterales ampC β-lactamase carbapenem clinical trial piperacillin-tazobactam 10.1093/ofid/ofab387 Open Forum Infectious Diseases 8 8 ofab387- 2021-11-15T09:03:46Z 2021-11-15T09:03:46Z 2021-08-01 2021-11-11T06:10:17Z Article Stewart, AG, Paterson, DL, Young, B, Lye, DC, Davis, JS, Schneider, K, Yilmaz, M, Dinleyici, R, Runnegar, N, Henderson, A, Archuleta, S, Kalimuddin, S, Forde, BM, Chatfield, MD, Bauer, MJ, Lipman, J, Harris-Brown, T, Harris, PNA (2021-08-01). Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Caused by AmpC β-Lactamase-Producing Enterobacter spp, Citrobacter freundii, Morganella morganii, Providencia spp, or Serratia marcescens: A Pilot Multicenter Randomized Controlled Trial (MERINO-2). Open Forum Infectious Diseases 8 (8) : ofab387-. ScholarBank@NUS Repository. https://doi.org/10.1093/ofid/ofab387 23288957 https://scholarbank.nus.edu.sg/handle/10635/206194 Oxford University Press (OUP) Elements
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic Enterobacterales
ampC β-lactamase
carbapenem
clinical trial
piperacillin-tazobactam
spellingShingle Enterobacterales
ampC β-lactamase
carbapenem
clinical trial
piperacillin-tazobactam
Stewart, AG
Paterson, DL
Young, B
Lye, DC
Davis, JS
Schneider, K
Yilmaz, M
Dinleyici, R
Runnegar, N
Henderson, A
Archuleta, S
Kalimuddin, S
Forde, BM
Chatfield, MD
Bauer, MJ
Lipman, J
Harris-Brown, T
Harris, PNA
Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Caused by AmpC β-Lactamase-Producing Enterobacter spp, Citrobacter freundii, Morganella morganii, Providencia spp, or Serratia marcescens: A Pilot Multicenter Randomized Controlled Trial (MERINO-2)
description 10.1093/ofid/ofab387
author2 MEDICINE
author_facet MEDICINE
Stewart, AG
Paterson, DL
Young, B
Lye, DC
Davis, JS
Schneider, K
Yilmaz, M
Dinleyici, R
Runnegar, N
Henderson, A
Archuleta, S
Kalimuddin, S
Forde, BM
Chatfield, MD
Bauer, MJ
Lipman, J
Harris-Brown, T
Harris, PNA
format Article
author Stewart, AG
Paterson, DL
Young, B
Lye, DC
Davis, JS
Schneider, K
Yilmaz, M
Dinleyici, R
Runnegar, N
Henderson, A
Archuleta, S
Kalimuddin, S
Forde, BM
Chatfield, MD
Bauer, MJ
Lipman, J
Harris-Brown, T
Harris, PNA
author_sort Stewart, AG
title Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Caused by AmpC β-Lactamase-Producing Enterobacter spp, Citrobacter freundii, Morganella morganii, Providencia spp, or Serratia marcescens: A Pilot Multicenter Randomized Controlled Trial (MERINO-2)
title_short Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Caused by AmpC β-Lactamase-Producing Enterobacter spp, Citrobacter freundii, Morganella morganii, Providencia spp, or Serratia marcescens: A Pilot Multicenter Randomized Controlled Trial (MERINO-2)
title_full Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Caused by AmpC β-Lactamase-Producing Enterobacter spp, Citrobacter freundii, Morganella morganii, Providencia spp, or Serratia marcescens: A Pilot Multicenter Randomized Controlled Trial (MERINO-2)
title_fullStr Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Caused by AmpC β-Lactamase-Producing Enterobacter spp, Citrobacter freundii, Morganella morganii, Providencia spp, or Serratia marcescens: A Pilot Multicenter Randomized Controlled Trial (MERINO-2)
title_full_unstemmed Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Caused by AmpC β-Lactamase-Producing Enterobacter spp, Citrobacter freundii, Morganella morganii, Providencia spp, or Serratia marcescens: A Pilot Multicenter Randomized Controlled Trial (MERINO-2)
title_sort meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections caused by ampc β-lactamase-producing enterobacter spp, citrobacter freundii, morganella morganii, providencia spp, or serratia marcescens: a pilot multicenter randomized controlled trial (merino-2)
publisher Oxford University Press (OUP)
publishDate 2021
url https://scholarbank.nus.edu.sg/handle/10635/206194
_version_ 1821223591025311744